$ICPT News Drug companies Salix, Intercept reeling

New Post Public Reply Private Reply Replies (0) Message Board

Nov 16, 2014 at 1:53 PM

$ICPT News

Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
U.S. stocks end lower; Dow turns negative for the year 3:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 1:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 10:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 7:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 12:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 3:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape 8:34 a.m. Nov. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Is Weak On High Volume Today 10:00 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals (ICPT) Downgraded From Hold to Sell 9:21 a.m. Nov. 12, 2014 - TheStreet.com
Intercept Pharmaceuticals' (ICPT) AASLD Investor Event - Transcript 1:54 p.m. Nov. 11, 2014 - Seeking Alpha
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog 1:50 p.m. Nov. 11, 2014 - Zacks.com
Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog 5:03 p.m. Nov. 10, 2014 - Zacks.com
Intercept Seen as Poster-boy for Possible Biotech Bubble 2:58 p.m. Nov. 10, 2014 - TheStreet.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Intercept Pharmaceuticals (ICPT) Marked As A Dead Cat Bounce Stock 9:48 a.m. Nov. 10, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Intercept Pharmaceuticals (ICPT) Trading With Heavy Volume Before Market Open 8:34 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: INTERCEPT PHARMACEUTICALS INC 5:24 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog 4:02 p.m. Nov. 6, 2014 - Zacks.com
Meet The 5 Companies Loving Obamacare 7:04 p.m. Nov. 4, 2014 - Benzinga.com
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Biotech Stocks With Upside Target Ebola, Liver Disease 6:30 a.m. Sept. 16, 2014 - InvestorPlace.com
Is Intercept Pharmaceuticals Building The Next Great Specialty Franchise? 2:30 p.m. Sept. 15, 2014 - Seeking Alpha
Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino 9:16 a.m. Sept. 11, 2014 - Seeking Alpha

Intercept Announces Additional Data for OCA in Primary Biliary Cirrhosis 8:02 a.m. Nov. 8, 2014 - GlobeNewswire
FLINT Trial in NASH Published in The Lancet 7:06 p.m. Nov. 6, 2014 - GlobeNewswire
Intercept to Report Third Quarter 2014 Results on November 7 and Present at Upcoming Conferences 5:02 a.m. Oct. 31, 2014 - GlobeNewswire
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 7:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By InvestorsObserver 8:31 a.m. Oct. 8, 2014 - PR Newswire - PRF
Intercept Announces Data to be Presented at the 2014 AASLD Annual Meeting 5:30 a.m. Oct. 8, 2014 - GlobeNewswire
Quarterly Changes to the NASDAQ Q-50 Index 6:06 a.m. Sept. 15, 2014 - GlobeNewswire
Intercept Pharmaceuticals Recognizes International PBC Day 5:56 a.m. Sept. 12, 2014 - GlobeNewswire
Critical Alerts For Apple, Kinder Morgan, Stratasys, Intercept Pharmaceuticals and NPS Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Sept. 8, 2014 - PR Newswire - PRF
Intercept to Present at Upcoming Investor Conferences 7:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 8:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 8:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 4:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 9:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 9:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 8:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 4:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 6:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 10:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Busch Gardens' Holiday Extravaganza Lights Up 2026

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Banco Santander's Troubles: Legal Heat on SAN

Brazilian Turbulence Shakes Banco Santander Imagine getting hit twice in a single week, once by a surprise election result and again by numbers that don't add up. That's the gut-wrenching scenario Banco Santander's (NYSE: SAN) investors are facing. After Brazil's unexpected election outcome, investor jitters translated into a 3.7% drop on October 26, 2026. Not two days...

Pelvic Health Initiative Aids Women in Need

Stepping Up For Better Health You don't see this kind of news getting plastered across the financial pages much—the human side of health. EliHealth Initiative's making strides in a realm many don’t even want to openly discuss: bladder leaks in women. Sounds unglamorous, maybe, but for millions, it's a daily ordeal. Slapping on pads and plotting bathroom routes? That's...

Summit Hotel Welcomes New CFO, Promotes Veteran COO

Summit Hotel Properties Shakes Up Leadership Ah, the hotel industry. Sometimes as glitz and glam as Beverly Hills, sometimes as harried as a concierge juggling suitcases. Now, Summit Hotel Properties is playing its hand, reshuffling the deck with some keen leadership moves. Swapping out the four of spades for some aces, if you ask me. On November 1st, they’re bringing...

Sage Longboat Key Condos Battle Florida's Marine Climate

Building Resilience on Florida's Shores If you've ever had your eyes on some beachfront real estate down in Florida, you'd know it's not all sandy beaches and sunsets. It's a constant battle against the elements, my friends. The Sage Longboat Key condominiums in Sarasota have taken this challenge head-on with some serious innovation. The Condominium Dream Sitting pretty...

JOIA Rose Hall Revives Jamaican Luxury Experience

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Tata's $450M Bet on India's AI Infrastructure

The Big Bet on AI Infrastructure Here comes Tata Communications, tossing nearly USD 450 million into the pot, betting on a vision that could change India's digital backbone. This isn't just some drop in the bucket; they're talking about laying down 10,000 kilometers of fiber for India's AI super highway. It's a gutsy move, and frankly, it's about time someone shook things...

Cerebras Faces Durability Allegations: Investor Alert

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Max Stock Gears Up for Q3 Earnings Report Nov. 17

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

Keith Strachan Elevates The Master Group's Strategy

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...